INTRODUCTION
============

Cell polarization is crucial for many cellular processes in both single-celled and multicellular organisms, including localized membrane growth, directional cell migration, and differentiation. The direction of cell polarization is determined by specific spatial cues provided by the environment (such as chemoattractant gradients) or cell history (such as bud scars in yeast; [@B14]). The initial signals for the establishment of polarity are first detected at the plasma membrane and then transmitted via signaling pathways to various cellular targets. A major cellular target for these signaling events is the actin cytoskeleton, which undergoes rearrangements to bring about polarization ([@B28]).

The budding yeast S. cerevisiae is an excellent model system for studies of dynamics of the actin cytoskeleton because yeast has a relatively simple actin cytoskeleton and offers powerful experimental tools. Throughout the yeast cell cycle, precisely choreographed changes in the organization of the actin cytoskeleton underlie spatial control of cell surface growth and thereby determine cell morphology. Extension of the cell surface is preceded by the polarized organization of two actin filament--containing structures: actin cables and cortical actin patches ([@B60]). The small GTPase Cdc42p is a key member of the upstream signaling network for spatial organization of these actin structures. Cdc42p is active in its GTP-bound form, but is inactive in its GDP-bound form. Cdc42p-GTP interacts with various effector molecules to assemble actin filaments, to promote docking and fusion of secretory vesicles and to coordinate signaling events leading to bud formation ([@B59]; [@B8]; [@B56]). In the initial stage of budding, Cdc24p and Bem1p play pivotal roles in the activation of Cdc42p as well as its recruitment to the bud site. Cdc24p is a GDP/GTP exchange factor that activates Cdc42p, and Bem1p acts as a scaffold at the bud site by interacting with Cdc24p and Cdc42p-GTP ([@B59]; [@B33]; [@B56]).

Actin cables consist of parallel bundles of actin filaments stabilized by tropomyosins (Tpm1p and Tpm2p) and serve as tracks for type V myosin Myo2p-driven transport of secretory vesicles, vacuoles, Golgi membranes, proteins, and RNAs ([@B9]). The nucleation and assembly of actin cables require the action of the formins Bni1p and Bnr1p. Formins are a family of highly conserved eukaryotic proteins that are implicated in a wide range of actin-based processes. They contain two conserved juxtaposed formin homology (FH) domains, FH1 and FH2. The proline-rich FH1 domain binds to the actin-monomer--binding protein profilin (Pfy1p), whereas the FH2 domain is sufficient for actin filament nucleation in vitro ([@B19]). The FH2 domain also binds to the filament\'s barbed end, modulating its elongation and protecting it from capping proteins ([@B89]). Bni1p is part of a 12S complex termed the polarisome, which also includes Spa2p, Pea2p, and Bud6p ([@B72]). Polarisome components are required for apical growth; in their absence, cells fail to confine the growth site to a small region during initial bud emergence and bud growth.

Formation and reorganization of cortical actin patches are regulated by cortical patch-like protein structures, including the Arp2/3 complex and several of its activators, as well as endocytic adaptors and scaffolds ([@B60]). The Arp2/3 complex nucleates new actin filaments from the side of existing filaments to form a branched actin filament network ([@B26]). Activators of Arp2/3 in yeast includes the Wiskott-Aldrich syndrome protein (WASP) homologue Las17p, type I myosins Myo3p and Myo5p, and an Eps15 homology (EH) protein Pan1p ([@B82]). Cortical actin patches and their associated proteins function in the internalization process of endocytosis ([@B16]); actin patches assemble at the plasma membrane as the endocytic vesicle forms, and many proteins are recruited to the actin patch, including endocytic adaptors Sla1p, Sla2p, End3p, and Pan1p ([@B37]). However, roles of Arp2/3-mediated actin assembly in cell polarity remain obscure in budding yeast.

In this study, we show that yeast cells form a small bud in the absence of actin cables, indicating that they can polarize without actin cable--dependent vesicle transport. Additional mutations in genes for actin patch components inhibited this polarized growth. Our results suggest that the Arp2/3 system contributes to polarized growth by promoting endocytic membrane recycling.

MATERIALS AND METHODS
=====================

Strains and Plasmids
--------------------

Yeast strains used in this study are listed in [Table 1](#T1){ref-type="table"}. Yeast strains carrying complete gene deletions (*end3*Δ and *vps54*Δ), C-terminally green fluorescent protein (GFP)-tagged genes (*SPC42* and *MYO2*), C-terminally enhanced GFP (EGFP)-tagged genes (*bni1-116* and *BEM1*), and C-terminally monomeric red fluorescent protein 1 (mRFP1)-tagged *SPA2* were constructed by PCR-based procedures as described ([@B49]; [@B25]). Strains carrying *SPA2-GFP* and *EXO70-GFP* were constructed by integrating the linearized plasmid p406S2G (pRS406-SPA2-GFP; [@B2]) and pRS306-hemi-EXO70-GFP (a gift from Peter Novick, Yale University School of Medicine) at the *URA3* locus. *tlg2* and *pep8* disruption mutants were constructed by introducing PCR-amplified alleles disrupted with *KanMX4* in BY4741 ([@B86]). All strains constructed by PCR-based procedures were verified by colony-PCR amplification to confirm that the replacement had occurred at the expected locus. The *tpm1-2 tpm2*Δ, *pfy1-116*, *arp2-2*, *sec4-2*, *myo2-66*, *myo2-12*, and *myo2-20* mutants in the YEF473 genetic background were constructed by backcrossing three times. The *bni1-11* and *bni1-FH2*\#*2* alleles were generated using a QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) with pRS314-BNI1 ([@B36]). The entire open reading frame of *BNI1* was sequenced to verify that only the desired substitutions were introduced. pRS416-GFP-SNC1 was a gift from Hugh Pelham (MRC Laboratory of Molecular Biology; [@B47]). Schemes detailing the construction of plasmids and DNA sequences of nucleotide primers are available on request.

###### 

Yeast strains used in this study

  Strain[^a^](#TF1-1){ref-type="table-fn"}    Genotype                                                                                                         Source or reference
  ------------------------------------------- ---------------------------------------------------------------------------------------------------------------- ---------------------
  ABY944                                      *MAT*a *tpm1-2::LEU2 tpm2*Δ*::HIS3 his3*Δ*-200 leu2-3,112 lys2-801 trp1-1 ura3-52*                               [@B62]
  YMW221U                                     *MAT*a *arp2-2(G19D)::URA3 ade2-101 his3*Δ*-200 leu2*Δ*-1 lys2-801 trp1*Δ*-63 ura3-52*                           [@B50]
  ANS4-8A                                     *MAT*α *sec4-2*                                                                                                  [@B54]
  JP7A                                        *MAT*a *myo2-66 ade1 his6 leu2-3,112 ura3-52*                                                                    [@B35]
  ABY532                                      *MAT*α *myo2-12::HIS3 his3*Δ*-200 ura3-52 leu2-3,112 lys2-801 ade2-101*                                          [@B71]
  ABY530                                      *MAT*α *myo2-20::HIS3 his3*Δ*-200 ura3-52 leu2-3,112 lys2-801 ade2-101*                                          [@B71]
  BY4743                                      *MAT*a/α *LYS2/lys2*Δ*0 ura3*Δ*0/ura3*Δ*0 his3*Δ*1/his3*Δ*1 leu2*Δ*0/leu2*Δ*0 met15*Δ*0/MET15*                   [@B86]
  YEF473                                      *MAT*a/α *ura3-52/ura3-52 his3*Δ*-200/his3*Δ*-200 trp1*Δ*-63/trp1*Δ*-63 leu2*Δ*-1/leu2*Δ*-1 lys2-801/lys2-801*   [@B6]
  YKT38                                       *MAT*a *ura3-52 his3*Δ*-200 trp1*Δ*-63 leu2*Δ*-1 lys2-801*                                                       [@B53]
  YKT39                                       *MAT*α *ura3-52 his3*Δ*-200 trp1*Δ*-63 leu2*Δ*-1 lys2-801*                                                       [@B68]
  YEF2669                                     *MAT*a *bni1-116 bnr1*Δ*::HIS3MX6*                                                                               [@B36]
  YKT505                                      *MAT*α *bnr1*Δ*::HphMX4*                                                                                         This study
  YKT503                                      *MAT*a *bni1-116 bnr1*Δ*::HphMX4*                                                                                This study
  YKT382                                      *MAT*a *bni1*Δ*::HIS3MX6*                                                                                        [@B36]
  YKT390                                      *MAT*a *bnr1*Δ*::HphMX4*                                                                                         This study
  YKT458                                      *MAT*a/α *bni1-116/bni1-116 bnr1*Δ*::KanMX6/bnr1*Δ*::KanMX6*                                                     This study
  YKT1312                                     *MAT*a *bni1*Δ*::HIS3MX6 bnr1*Δ*::KanMX6* \[pRS314-bni1-11\]                                                     This study
  YKT1313                                     *MAT*a *bni1*Δ*::HIS3MX6 bnr1*Δ*::KanMX6* \[pRS314-bni1-FH2\#1\]                                                 This study
  YKT476                                      *MAT*a *tpm1-2::LEU2 tpm2*Δ*::HIS3*                                                                              This study
  YKT533                                      *MAT*α *bni1-116-EGFP::KanMX6 bnr1*Δ*::HphMX4*                                                                   This study
  YKT978                                      *MAT*a *tpm1-2::LEU2 tpm2*Δ*::HIS3 bni1-116-EGFP::KanMX6 bnr1*Δ*::HphMX4*                                        This study
  YKT977                                      *MAT*a *pfy1-116::LEU2*                                                                                          [@B87]
  YKT1545                                     *MAT*a *pfy1-116::LEU2 bni1-116-EGFP::HIS3MX6 bnr1*Δ*::HphMX4*                                                   This study
  YKT1514                                     *MAT*a *SPC42-GFP::HIS3MX6*                                                                                      This study
  YKT1516                                     *MAT*a *SPC42-GFP::KanMX6*                                                                                       This study
  YKT1550                                     *MAT*a *bni1-116 bnr1*Δ*::HphMX4 SPC42-GFP::HIS3MX6*                                                             This study
  YKT1552                                     *MAT*a *tpm1-2::LEU2 tpm2*Δ*::HIS3 SPC42-GFP::KanMX6*                                                            This study
  YKT1684[^a^](#TF1-1){ref-type="table-fn"}   *MAT*a *tpm1-2::LEU2 tpm2*Δ*::HIS3 SPC42-GFP::KanMX6*                                                            This study
  YKT1561                                     *MAT*a *BEM1-EGFP::HIS3MX6*                                                                                      This study
  YKT1562                                     *MAT*a *bni1-116 bnr1*Δ*::HphMX4 BEM1-EGFP::HIS3MX6*                                                             This study
  YKT570                                      *MAT*a *URA3::SPA2-GFP*                                                                                          This study
  YKT1584                                     *MAT*a *bni1-116 bnr1*Δ*::HphMX4 URA3::SPA2-GFP*                                                                 This study
  YKT1370                                     *MAT*a *URA3::EXO70-GFP*                                                                                         This study
  YKT1574                                     *MAT*a *bni1-116 bnr1*Δ*::HphMX4 URA3::EXO70-GFP*                                                                This study
  YKT1553                                     *MAT*a *arp2-2::URA3 SPC42-GFP::HIS3MX6*                                                                         This study
  YKT1554                                     *MAT*a *arp2-2::URA3 bni1-116 bnr1*Δ*::HphMX4 SPC42-GFP::HIS3MX6*                                                This study
  YKT1554                                     *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6 SPC42-GFP::HIS3MX6*                                                         This study
  YKT1555                                     *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6 bni1-116 bnr1*Δ*::HphMX4 SPC42-GFP::HIS3MX6*                                This study
  YKT1557                                     *MAT*a *sla2-82::KanMX6 SPC42-GFP::HIS3MX6*                                                                      This study
  YKT1558                                     *MAT*a *sla2-82::KanMX6 bni1-116 bnr1*Δ*::HphMX4 SPC42-GFP::HIS3MX6*                                             This study
  YKT1600                                     *MAT*a *end3*Δ*::KanMX6 bni1-116-EGFP::KanMX6 bnr1*Δ*::HphMX4*                                                   This study
  YKT1601[^a^](#TF1-1){ref-type="table-fn"}   *MAT*a *sla1*Δ*::KanMX4 bni1*Δ*::HIS3MX6 bnr1*Δ*::KanMX6* \[pRS316-bni1-116\]                                    This study
  YKT478                                      *MAT*a *arp2-2(G19D)::URA3*                                                                                      This study
  YKT1546                                     *MAT*a *arp2-2(G19D)::URA3 bni1-116 bnr1*Δ*::HphMX4*                                                             This study
  YKT91                                       *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6*                                                                            [@B78]
  YKT1547                                     *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6 bni1-116 bnr1*Δ*::HphMX4*                                                   This study
  YKT850                                      *MAT*a *sla2-82::KanMX6*                                                                                         This study
  YKT1548                                     *MAT*a *sla2-82::KanMX6 bni1-116 bnr1*Δ*::HphMX4*                                                                This study
  YKT1566                                     *MAT*a *arp2-2(G19D)::URA3 BEM1-EGFP::HIS3MX6*                                                                   This study
  YKT1567                                     *MAT*a *arp2-2(G19D)::URA3 bni1-116 bnr1*Δ*::HphMX4 BEM1-EGFP::KanMX6*                                           This study
  YKT1568                                     *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6 BEM1-EGFP::HIS3MX6*                                                         This study
  YKT1569                                     *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6 bni1-116 bnr1*Δ*::HphMX4 BEM1-EGFP::HIS3MX6*                                This study
  YKT1570                                     *MAT*a *sla2-82::KanMX6 BEM1-EGFP::HIS3MX6*                                                                      This study
  YKT1571                                     *MAT*a *sla2-82::KanMX6 bni1-116 bnr1*Δ*::HphMX4 BEM1-EGFP::HIS3MX6*                                             This study
  YKT1586                                     *MAT*a *arp2-2(G19D)::URA3 URA3::SPA2-GFP*                                                                       This study
  YKT1587                                     *MAT*a *arp2-2(G19D)::URA3 bni1-116 bnr1*Δ*::HphMX4 SPA2-GFP::TRP1*                                              This study
  YKT1588                                     *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6 URA3::SPA2-GFP*                                                             This study
  YKT1589                                     *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6 bni1-116 bnr1*Δ*::HphMX4 URA3::SPA2-GFP*                                    This study
  YKT1590                                     *MAT*a *sla2-82::KanMX6 URA3::SPA2-GFP*                                                                          This study
  YKT1591                                     *MAT*a *sla2-82::KanMX6 bni1-116 bnr1*Δ*::HphMX4 URA3::SPA2-GFP*                                                 This study
  YKT1576                                     *MAT*a *arp2-2(G19D)::URA3 URA3::EXO70-GFP*                                                                      This study
  YKT1577                                     *MAT*a *arp2-2(G19D)::URA3 bni1-116 bnr1*Δ*::HphMX4 URA3::EXO70-GFP*                                             This study
  YKT1578                                     *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6 URA3::EXO70-GFP*                                                            This study
  YKT1579                                     *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6 bni1-116 bnr1*Δ*::HphMX4 URA3::EXO70-GFP*                                   This study
  YKT1580                                     *MAT*a *sla2-82::KanMX6 URA3::EXO70-GFP*                                                                         This study
  YKT1581                                     *MAT*a *sla2-82::KanMX6 bni1-116 bnr1*Δ*::HphMX4 URA3::EXO70-GFP*                                                This study
  YKT1559                                     *MAT*a *tlg2*Δ*::KanMX4 SPC42-GFP::HIS3MX6*                                                                      This study
  YKT1560                                     *MAT*a *tlg2*Δ*::KanMX4 bni1-116 bnr1*Δ*::HphMX4 SPC42-GFP::HIS3MX6*                                             This study
  YKT1602                                     *MAT*a *vps54*Δ*::KanMX6 SPC42-GFP::HIS3MX6*                                                                     This study
  YKT1603                                     *MAT*a *vps54*Δ*::KanMX6 bni1-116 bnr1*Δ*::HphMX4 SPC42-GFP::HIS3MX6*                                            This study
  YKT1605                                     *MAT*a *pep8*Δ*::KanMX4 SPC42-GFP::HIS3MX6*                                                                      This study
  YKT1606                                     *MAT*a *pep8*Δ*::KanMX4 bni1-116 bnr1*Δ*::HphMX4 SPC42-GFP::HIS3MX6*                                             This study
  YKT955                                      *MAT*a *tlg2*Δ*::KanMX4*                                                                                         This study
  YKT1549                                     *MAT*a *tlg2*Δ*::KanMX4 bni1-116 bnr1*Δ*::HphMX4*                                                                This study
  YKT1572                                     *MAT*a *tlg2*Δ*::KanMX4 BEM1-EGFP::HIS3MX6*                                                                      This study
  YKT1573                                     *MAT*a *tlg2*Δ*::KanMX4 bni1-116 bnr1*Δ*::HphMX4 BEM1-EGFP::KanMX6*                                              This study
  YKT1592                                     *MAT*a *tlg2*Δ*::KanMX4 URA3::SPA2-GFP*                                                                          This study
  YKT1593                                     *MAT*a *tlg2*Δ*::KanMX4 bni1-116 bnr1*Δ*::HphMX4 URA3::SPA2-GFP*                                                 This study
  YKT1582                                     *MAT*a *tlg2*Δ*::KanMX4 URA3::EXO70-GFP*                                                                         This study
  YKT1583                                     *MAT*a *tlg2*Δ*::KanMX4 bni1-116 bnr1*Δ*::HphMX4 URA3::EXO70-GFP*                                                This study
  YKT1608                                     *MAT*a *sec4-2 SPC42-GFP::HIS3MX6*                                                                               This study
  YKT1611                                     *MAT*a *sec4-2 BEM1-EGFP::KanMX6*                                                                                This study
  YKT1610                                     *MAT*a *myo2-66 SPC42-GFP::HIS3MX6*                                                                              This study
  YKT1612                                     *MAT*a *myo2-66 BEM1-EGFP::KanMX6*                                                                               This study
  YKT1679                                     *MAT*a *myo2-12::HIS3 SPC42-GFP::KanMX6*                                                                         This study
  YKT1680                                     *MAT*a *myo2-12::HIS3 BEM1-EGFP::KanMX6*                                                                         This study
  YKT1677                                     *MAT*a *myo2-20::HIS3 SPC42-GFP::KanMX6*                                                                         This study
  YKT1681                                     *MAT*a *myo2-20::HIS3 BEM1-EGFP::KanMX6*                                                                         This study
  YKT791                                      *MAT*a *bni1-116 bnr1*Δ*::HphMX4 MYO2-GFP::TRP1*                                                                 This study
  YKT1614                                     *MAT*a *myo3*Δ*::TRP1 myo5-1::KanMX6 bni1-116 bnr1*Δ*::HphMX4 MYO2-GFP::TRP1*                                    This study
  YKT1615                                     *MAT*a *sla2-82::KanMX6 bni1-116 bnr1*Δ*::HphMX4 MYO2-GFP::TRP1*                                                 This study
  YKT1616                                     *MAT*a *tlg2*Δ*::KanMX4 MYO2-GFP::TRP1*                                                                          This study
  YKT1617                                     *MAT*a *tlg2*Δ*::KanMX4 bni1-116 bnr1*Δ*::HphMX4 MYO2-GFP::TRP1*                                                 This study

^a^ YKT strains are isogenic derivatives of YEF473, except YKT1684 and YKT1601, which are ABY944 and BY4743 derivatives, respectively. Only relevant genotypes are described.

Media and Genetic Methods
-------------------------

Strains were cultured in YPDA rich medium (1% yeast extract \[Difco Laboratories, Detroit, MI\], 2% bacto-peptone \[Difco\], 2% glucose, and 0.01% adenine). Strains carrying *URA3*-harboring plasmids were selected in synthetic medium containing 0.5% casamino acids (Difco), 0.03% tryptophan, and 0.01% adenine (SDA-U). Standard genetic manipulations of yeast were performed as described previously ([@B27]). The lithium acetate method was used for transformation of yeast cells ([@B15]; [@B24]).

Microscopic Observations
------------------------

To observe filamentous actin, strains were grown to midlogarithmic phase at 18°C and then shifted to 35°C for 5 min. Cells were fixed in 3.7% formaldehyde and stained with tetramethylrhodamine B isothiocyanate (TRITC)-phalloidin (Sigma Chemical, St. Louis, MO) as described ([@B53]). Initial budding morphology and initial polarization of polarity regulators were examined in cells exiting from cell cycle arrest. Cells were synchronized in the G1 phase of the cell cycle by the addition of α-factor and released from the block by removal thereof. In brief, cells were grown to logarithmic phase, pelleted, and resuspended in YPDA containing 1 μg/ml α-factor (Sigma Chemical) at 1.7 × 10^6^ cells/ml. When cells exhibited shmoos (for 2 h), they were washed with 10 ml of cold YP (1% yeast extract, 2% bacto-peptone) three times and released into fresh YPDA at the indicated temperature. Bud morphology was visually categorized as unbudded, small-budded (longest diameter of the bud is smaller than one-third the longest diameter of the mother cell), medium-budded (between one- and two-thirds), or large-budded (larger than two-thirds).

Immunostaining of Cdc42p was performed essentially as described using rabbit anti-Cdc42p polyclonal antibody diluted at 1:500 ([@B43]). Cy3-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) diluted at 1:500 was used as a secondary antibody. GFP-Snc1p was observed in living cells, whereas other GFP-, EGFP-, or mRFP1-tagged proteins were observed in fixed cells. Fixation was performed by direct addition of a commercial 37% formaldehyde stock (Wako Pure Chemicals, Osaka, Japan) to the culture medium to a final concentration of 3.7%, followed by a 10-min incubation. After fixation, cells were washed twice with phosphate-buffered saline and examined using a Nikon ECLIPSE E800 microscope (Nikon Instec, Tokyo, Japan) equipped with an HB-10103AF super-high-pressure mercury lamp and a 1.4 NA 100× Plan Apo oil immersion objective with the appropriate fluorescence filter sets and differential interference contrast (DIC) optics. Images were acquired with a digital cooled charge-coupled device camera (C4742-95-12NR; Hamamatsu Photonics, Hamamatsu, Japan) using AQUACOSMOS software (Hamamatsu Photonics). Observations are compiled from the examination of at least 200 cells or cell numbers as indicated in the text.

RESULTS
=======

Loss of Actin Cables in Temperature-sensitive bni1 bnr1 Mutants Causes Characteristic Growth Arrest with a Small Bud
--------------------------------------------------------------------------------------------------------------------

We previously constructed strains that harbored temperature-sensitive (ts) *bni1* alleles in the *bnr1*Δ background by random mutagenesis ([@B36]). All of these mutant strains showed a similar small-budded phenotype at the restrictive temperature (see below; our unpublished results). We selected one such mutation, *bni1-116* and analyzed it further. The temperature-sensitive growth phenotype of the *bni1-116 bnr1*Δ mutant is shown in [Figure 1](#F1){ref-type="fig"}A. Bni1-116p contained the amino acid substitutions (V1475A, K1498E, and D1511N) within the FH2 domain ([@B36]). After shift to 35°C, actin cables disappeared from the *bni1-116 bnr1*Δ mutant cells within 5 min ([Figure 1](#F1){ref-type="fig"}B). GFP-tagged Myo2p also disappeared from polarized growth sites, such as the bud tip and cytokinesis site in *bni1-116 bnr1*Δ mutant cells 5 min after temperature shift (data not shown). These results indicate that Bni1-116p is incapable of nucleating actin and assembling actin cables at the restrictive temperature.

![The *bni1-116 bnr1*Δ mutant shows growth arrest with a small bud. (A) Temperature-sensitive growth in the *bni1-116 bnr1*Δ mutant. Strains were streaked onto YPDA plates, followed by incubation at 25°C for 3 d or at 35°C for 2 d. Strains were wild type (WT, YKT38), *bni1*Δ (YKT382), *bnr1*Δ (YKT390), and *bni1-116 bnr1*Δ (YKT503). (B) Filamentous actin structures in the *bni1-116 bnr1*Δ mutant. Strains were grown in YPDA medium at 18°C and then shifted to 35°C for 5 min. Cells were fixed and stained for filamentous actin with TRITC-phalloidin. Strains were wild type (YKT7) and *bni1-116/bni1-116 bnr1*Δ*/bnr1*Δ (YKT458). (C) Growth arrest with a small bud in *bni1-116 bnr1*Δ cells. Exponentially growing wild-type (YKT38) and *bni1-116 bnr1*Δ (YKT503) cells were shifted to 37°C and fixed with 3.7% formaldehyde at the indicated time point. The graph shows the percentage of cells with the bud size that was categorized as described in *Materials and Methods*. The right panel displays images of cells after a 160-min incubation. (D) Time course of small-bud formation after release from G1 arrest. Wild-type (YKT38) and *bni1-116 bnr1*Δ (YKT503) cells were arrested with α-factor as described in *Materials and Methods* and released into fresh medium at 37°C, followed by fixation with 3.7% formaldehyde at the indicated time point. The graph shows the percentage of cells with the bud size as in C. Right, images of cells after incubation for the indicated time periods. Bars, 5 μm.](zmk0071094100001){#F1}

Interestingly, most *bni1-116 bnr1*Δ cells were arrested with a small bud at the restrictive temperature ([Figure 1](#F1){ref-type="fig"}C). After a 160-min incubation of an asynchronous culture at 37°C, the population of small-budded cells increased to 84% ([Figure 1](#F1){ref-type="fig"}C). These results show that the *bni1-116 bnr1*Δ mutant is able to complete cytokinesis once past the small-bud stage, but polarized growth is impeded soon after small-bud formation. This indicates that actin cables are not required for cytokinesis or polarized bud growth once the cells have proceeded past the small-bud stage. We examined the time course of small-bud formation at 37°C after release from G1 arrest. Wild-type and *bni1-116 bnr1*Δ cells were treated with α-factor for 2 h at 25°C, and the G1-arrested cells were released at 37°C. After 40 min, 16% of the wild-type cells formed a small bud (0.62 ± 0.24 μm in length, n = 125), whereas the *bni1-116 bnr1*Δ cells did not ([Figure 1](#F1){ref-type="fig"}D). After 60 min, 30% of the *bni1-116 bnr1*Δ cells formed a small bud; these buds were 0.35 ± 0.12 μm in length (n = 116), whereas the buds of the wild-type cells were 2.4 ± 0.57 μm in length (n = 121). After 160 min, 96% of the *bni1-116 bnr1*Δ cells were arrested with a small bud, as were those in asynchronous culture shifted to 37°C for 160 min. These results indicate that *bni1-116 bnr1*Δ cells can form a bud, albeit with a reduced speed, but these buds arrest when they are small. During the course of this study, similar observations were reported, although the mechanism underlying small-bud formation remains unknown ([@B4]).

These results were surprising, because the previously reported *bni1-11 bnr1*Δ mutant expanded isotropically into large unbudded cells like the temperature-sensitive *tpm1-2 tpm2*Δ tropomyosin mutant ([@B62]; [@B18]). The *bni1-11* mutation harbors two amino acid substitutions, D1511G and K1601R ([@B18]), whereas another ts allele of *BNI1*, *bni1-FH2*\#*1*, harbors R1528A and R1530A ([@B65]). All of these substitutions map to the FH2 domain. To examine whether the small-bud morphology is specific to the *bni1-116* allele, we constructed *bni1-11 bnr1*Δ and *bni1-FH2*\#*1 bnr1*Δ strains in our genetic background (YEF473 derivatives; [@B6]). When exponentially growing cells were transferred to 37°C for 3 h, most (∼95%) *bni1-11 bnr1*Δ and *bni1-FH2*\#*1 bnr1*Δ cells were arrested with a small bud ([Figure 2](#F2){ref-type="fig"}A). We also constructed *bni1-116 bnr1*Δ and *bni1-FH2*\#*1 bnr1*Δ strains in the BY4743 genetic background, which was used for the systematic deletion project ([@B86]). Again, most (∼93%) of these mutant cells were arrested with a small bud at 37°C (our unpublished results). Our results indicate that the small-budded phenotype is common to all three *bni1*-ts alleles in at least two genetic backgrounds.

![The small-budded phenotype is common to other *bni1-ts* alleles and the tropomyosin mutant. (A) Growth arrest with a small bud in other *bni1-ts bnr1*Δ mutants. *bni1*Δ *bnr1*Δ strains (YKT1312 and YKT1313) harboring pRS314-bni1-11 and pRS314-bni1-FH2\#1, respectively, were grown to early logarithmic phase and shifted to 37°C, followed by a 3-h incubation. Numbers indicate the percentage of small-budded cells. (B) Morphology of tropomyosin mutants with different genetic backgrounds. The α-factor--arrested *tpm1-2 tpm2*Δ (YEF) cells in the YEF473 strain background (YKT476) and the parental ABY944 *tpm1-2 tpm2*Δ (ABY; YKT286) cells were released into fresh medium at 37°C and fixed with 3.7% formaldehyde at the indicated time point. The graph shows the percentage of cells with the bud size that was categorized as described in *Materials and Methods*. Right, images of cells after incubation for the indicated time periods. (C) Morphology of *bni1-116 bnr1*Δ mutants with different genetic backgrounds. The *bni1-116-EGFP bnr1*Δ mutant (YKT533) in the YEF473 strain background was crossed with the *tpm1-2 tpm2*Δ (ABY) mutant (YKT286), and the resulting *bni1-116-EGFP bnr1*Δ progeny were morphologically examined. This allele of *bni1-116* contains the C-terminally-fused EGFP with a drug resistance marker for convenience in tetrad analysis; we confirmed that the *bni1-116-EGFP bnr1*Δ mutant was indistinguishable from the *bni1-116 bnr1*Δ mutant in morphological and growth phenotypes at 37°C (data not shown). Exponentially growing cells were shifted to 37°C, followed by a 3-h incubation. Top and middle, images of representative progeny with small-budded (clones 34c and 54c) and unbudded (clones 22c and 50c) phenotypes, respectively. These morphologically different clones were crossed, and the resulting diploids were cultured as described above (bottom panel, 34c × 50c and 54c × 22c). Bars, 5 μm.](zmk0071094100002){#F2}

Analysis of genetic differences between two genetic backgrounds might give us a clue about the mechanism of small-bud formation in the *bni1-116 bnr1*Δ mutant. Therefore, we included the *tpm1-2 tpm2*Δ (ABY944) strain that has a large unbudded phenotype at 37°C ([@B62]) in this study. We first examined whether the *tpm1-2 tpm2*Δ mutant in our YEF473 genetic background would exhibit the small-budded phenotype. We backcrossed the ABY944 *tpm1-2 tpm2*Δ (ABY) strain to our wild-type haploid (YKT39) three times to obtain a *tpm1-2 tpm2*Δ (YEF) mutant. The morphology of the parental *tpm1-2 tpm2*Δ (ABY) mutant and the *tpm1-2 tpm2*Δ (YEF) mutant was examined after α-factor-arrest-and-release at 37°C ([Figure 2](#F2){ref-type="fig"}B). After 80 min, 19% of the *tpm1-2 tpm2*Δ (YEF) cells formed a small bud, and after 160 min, 64% were arrested with a small or medium bud, although 31% exhibited unbudded morphology. Compared with the *bni1-116 bnr1*Δ mutant, the *tpm1-2 tpm2*Δ (YEF) mutant was arrested with a larger bud with a wider bud neck; the *tpm1-2* allele may be somewhat leaky, or formin-polymerized actin filaments may retain some function without tropomyosins. In contrast, most (83%) of the parental ABY944 *tpm1-2 tpm2*Δ mutant cells exhibited unbudded morphology as described previously ([@B62]), and only a small percentage (17%) formed a small bud after a 160-min incubation. When *tpm1-2 tpm2*Δ haploid progeny from a diploid between *tpm1-2 tpm2*Δ (ABY) and our wild type (YKT39) were examined microscopically at 37°C, small-budded and unbudded phenotypes were observed with a similar frequency (7:8) at a random spore basis. These results suggest that a single genetic trait is responsible for the small-budded versus unbudded phenotype.

We next examined whether this morphological difference between the two genetic backgrounds would also be observed for the *bni1-116 bnr1*Δ mutants. The *tpm1-2 tpm2*Δ (ABY) mutant was crossed with the *bni1-116 bnr1*Δ (YEF) mutant. The resulting diploid was tetrad-dissected, and 30 *bni1-116 bnr1*Δ progeny were morphologically examined. When cells that were exponentially growing at 25°C were shifted to 37°C for 3 h, 16 clones exhibited the small-budded phenotype (\>85% were arrested with a small bud), whereas 14 clones exhibited the unbudded phenotype (\>85% were arrested without a bud). The morphologies of representative clones are shown in [Figure 2](#F2){ref-type="fig"}C. When these morphologically different clones were crossed, the resulting diploids showed the small-budded phenotype ([Figure 2](#F2){ref-type="fig"}C, bottom panel). Taken together, these results imply that the ABY genetic background carries a single recessive mutation that is responsible for the defects in budding in the absence of actin cables. This gene seems to be involved in endocytosis (see below).

We wanted to exclude the possibility that the small-bud formation was due to leakiness of the *bni1* and *tpm1 ts* alleles. The *bni1-116 bnr1*Δ mutations were combined with the *tpm1-2 tpm2*Δ or *pfy1-116* mutations to construct a quadruple or triple mutant. Pfy1p stimulates formin-induced actin assembly in vitro, which requires its interactions with the FH1 domain and actin monomers ([@B66]; [@B42]; [@B58]). Exponentially growing cells were treated with α-factor at 25°C, and the G1-arrested cells were released at 37°C for 160 min. As shown in [Figure 3](#F3){ref-type="fig"}, 89% of the *tpm1-2 tpm2*Δ *bni1-116 bnr1*Δ cells formed a small bud. Similarly, 86% of the *pfy1-116 bni1-116 bnr1*Δ cells formed a small bud. The *pfy1-116* single mutant was not exclusively arrested with a small bud (47% small budded), because this mutant grew slowly at 37°C (data not shown). These results suggest that yeast cells possess a system to promote polarized growth independent of actin cables.

![Small-bud formation in actin cable-deficient mutants. α-factor--arrested cells were released into fresh medium at 37°C, followed by a 160-min incubation. The *pfy1-116* single mutant was incubated for 60 min after release, because this mutant grew slowly at 37°C. Strains examined were wild type (YKT38), *bni1-116 bnr1*Δ (YKT503), *tpm1-2 tpm2*Δ (YKT476), *tpm1-2 tpm2*Δ *bni1-116 bnr1*Δ (YKT978), *pfy1-116* (YKT977), and *pfy1-116 bni1-116 bnr1*Δ (YKT1545). Numbers indicate the percentage of small-budded cells. Bar, 5 μm.](zmk0071094100003){#F3}

Polarized Localization of Cdc42p and Polarity Regulators Is Normal in bni1-116 bnr1Δ Mutant Cells
-------------------------------------------------------------------------------------------------

It was reported that the *tpm1-2 tpm2*Δ mutant exhibited defects in polarized localization of Cdc42p ([@B61]; [@B34]; [@B88]); all of these studies used the *tpm1-2 tpm2*Δ mutant in the ABY genetic background. However, our results suggest that Cdc42p might be localized normally to the bud tip in an actin cable-independent manner. This would also be consistent with the fact that Cdc42p can be polarized in the presence of an actin inhibitor latrunculin-A ([@B3]). To examine this further, exponentially growing *bni1-116 bnr1*Δ cells were transferred to 37°C for 160 min and stained with affinity-purified polyclonal antibodies against Cdc42p ([@B43]). As expected, Cdc42p was localized at the bud tip in 87% of small-budded *bni1-116 bnr1*Δ cells ([Figure 4](#F4){ref-type="fig"}A); under our staining conditions, Cdc42p was detected in 93% of small-budded wild-type cells. We examined the initial polarization of Cdc42p in cells released from G1-arrest ([Figure 4](#F4){ref-type="fig"}B). Forty minutes after release, 28% of wild-type cells polarized Cdc42p at the presumptive bud site, but only 2% of *bni1-116 bnr1*Δ cells showed Cdc42p polarization (data not shown). Sixty and 160 min after release, 30 and 76% of *bni1-116 bnr1*Δ cells polarized Cdc42p, respectively. This time course for Cdc42p polarization, which is delayed compared with the wild type, is consistently similar to that for budding in *bni1-116 bnr1*Δ cells ([Figure 1](#F1){ref-type="fig"}D). To examine whether the delay in Cdc42p polarization in the *bni1-116 bnr1*Δ cells was caused by the delayed cell cycle progression, we monitored GFP-fused Spc42p, a component of the spindle pole body (SPB; [@B1]). When G1-arrested cells were released at 37°C for 60 min, the Spc42p-GFP dot was duplicated in 27 and 12% of wild-type and *bni1-116 bnr1*Δ cells, respectively ([Figure 4](#F4){ref-type="fig"}B), indicating that loss of actin cable assembly causes a delay in cell cycle progression. In our strain background, the *tpm1-2 tpm2*Δ mutant polarized Cdc42p and duplicated Spc42p-GFP in a manner similar to that in the *bni1-116 bnr1*Δ mutant; 60 and 160 min after release, 42 and 82% of *tpm1-2 tpm2*Δ cells, respectively, polarized Cdc42p. In contrast, in the ABY genetic background, Cdc42p was poorly polarized even after 160 min as reported previously ([@B61]; [@B34]; [@B88]). We noticed that the *bni1-116 bnr1*Δ mutant, but not the *tpm1-2 tpm2*Δ or *bnr1*Δ mutant (data not shown), accumulated Cdc42p to some cortical regions in addition to the bud tip ([Figure 4](#F4){ref-type="fig"}B, arrowheads).

![Cdc42p and polarity regulators are polarized to the bud emergence site and the bud tip in the *bni1-116 bnr1*Δ mutant. (A) Cdc42p polarization in an asynchronous culture of *bni1-116 bnr1*Δ cells. Exponentially growing wild-type (YKT38) and *bni1-116 bnr1*Δ (YKT503) cells were shifted to 37°C, and incubated for 160 min, followed by fluorescence immunostaining using the anti-Cdc42p antibody. In wild type, small-budded cells were selected and shown. (B) Initial polarization of Cdc42p in actin cable--deficient mutants. α-factor--arrested cells were released into fresh medium at 37°C, except for the *tpm1-2 tpm2*Δ (ABY) mutant (YKT1684), followed by fixation with 3.7% formaldehyde at the indicated time point. YKT1684 was released at 35°C because Spc42p was not duplicated at 37°C (our unpublished results). Cdc42p was visualized as described above. Cell cycle progression was examined by monitoring duplication of Spc42p-GFP. The graph shows the percentage of cells with Spc42p-GFP duplication (Spc42p) and polarized Cdc42p at the bud emergence site or the bud tip (Cdc42p). Bottom, images of representative cells with polarized or nonpolarized Cdc42p 60 min after release. Arrowheads, Cdc42p localized to cortical sites other than the budding site in the *bni1-116 bnr1*Δ mutant. Strains examined were Spc42p-GFP--expressing wild type (YKT1514), *bni1-116 bnr1*Δ (YKT1550), *tpm1-2 tpm2*Δ (YEF)(YKT1552), and *tpm1-2 tpm2*Δ (ABY) (YKT1684). (C) Polarized localization of polarity regulators in the *bni1-116 bnr1*Δ mutant. Strains were cultured and fixed, and polarization of each GFP-tagged polarity regulator was scored as described in B. Bottom, images of representative cells that polarized a GFP-fused protein after a 60-min incubation. The strains examined were Bem1p-GFP--expressing wild type (YKT1438) and *bni1-116 bnr1*Δ (YKT1562), Spa2p-GFP--expressing wild type (YKT570) and *bni1-116 bnr1*Δ (YKT1584), and Exo70p-GFP--expressing wild type (YKT1370) and *bni1-116 bnr1*Δ (YKT1574). Bars, 5 μm.](zmk0071094100004){#F4}

To confirm that bud formation in the *bni1-116 bnr1*Δ mutant occurs through a normal polarization process, we monitored the localization of other polarity regulators, Bem1p, Spa2p, and Exo70p. Exo70p is a component of the exocyst complex that is essential for exocytosis ([@B77]). Most components of the exocyst associate with the exocytic vesicles and are delivered to the bud tip in an actin cable-dependent manner, whereas a portion of Exo70p, like Sec3p, is transported to the bud tip in the absence of actin cables ([@B7]). When G1-arrested *bni1-116 bnr1*Δ cells were released at 37°C, these polarity regulators were polarized in time courses similar to that of Cdc42p ([Figure 4](#F4){ref-type="fig"}C), whereas Bem1p in the *tpm1-2 tpm2*Δ mutant with the ABY genetic background was poorly polarized (data not shown). Taken together, these results strongly suggest that the processes of initial cell polarization can occur independently of transport along actin cables.

Small-Bud Formation in the bni1-116 bnr1Δ Mutant Requires Arp2/3-dependent Actin Polymerization
-----------------------------------------------------------------------------------------------

F-actin assembly seems to be essential for bud formation, because treatment with latrunculin-A prevents bud formation ([@B3]; our unpublished results). Arp2p is a subunit of the Arp2/3 complex, which is the major known contributor to actin nucleation in vivo in yeast ([@B85]). Myo3/5p, type I myosins, are one of activators for the Arp2/3 complex ([@B17]; [@B44]). We next examined the involvement of Arp2/3-mediated actin assembly in small-bud formation in the *bni1-116 bnr1*Δ mutant. The temperature-sensitive *arp2-2* or *myo3*Δ *myo5-1* mutations were combined with the *bni1-116 bnr1*Δ mutation, and the resulting triple or quadruple mutants were examined for small-bud formation after release from G1 arrest with α-factor. We noticed that the *arp2-2* single mutant could not bud at all when released at 37°C, and this was due to the inhibition of cell cycle progression, as assessed by Spc42p-GFP duplication (data not shown). When released at 36°C, however, 45% of the *arp2-2* mutant cells duplicated Spc42p-GFP after a 160-min incubation, albeit with a lower efficiency than that observed in the *bni1-116 bnr1*Δ mutant cells (88%). Under these conditions (36°C, 160 min), 37% of the *arp2-2* cells formed a small or medium bud, whereas 97% of the *bni1-116 bnr1*Δ cells formed only a small bud (data not shown). In contrast, only 4% of the *arp2-2 bni1-116 bnr1*Δ cells formed a small bud ([Figure 5](#F5){ref-type="fig"}A), even though Spc42p-GFP duplication was seen in 59% of these cells. For *myo3*Δ *myo5-1*, α-factor--arrested cells were released at 37°C, because this mutant initiated budding at 37°C. The cells that started budding progressed into the medium-budded stage; 17 and 25% of the cells formed a small and medium buds, respectively, after a 160-min incubation. Under these conditions (37°C, 160 min), Spc42-GFP duplication was observed in 46% of the cells. However, only a minor fraction (6%) of the *myo3*Δ *myo5-1 bni1-116 bnr1*Δ mutant cells formed a small bud, although 54% duplicated Spc42p-GFP. These results suggest that Arp2/3p-dependent actin polymerization is required for the bud formation in the absence of actin cables.

![Small-bud formation in the *bni1-116 bnr1*Δ mutant requires Arp2/3-dependent actin assembly. (A) The *arp2-2* and *myo3*Δ *myo5-1* mutations inhibit small-bud formation in the *bni1-116 bnr1*Δ mutant. α-factor--arrested cells were released into fresh medium at 36°C (*arp2-2*) or 37°C (*myo3*Δ *myo5-1*), followed by fixation at the indicated time point. The graph shows the percentage of cells with Spc42p-GFP duplication (Spc42p) and the bud size as categorized in *Materials and Methods*. Bottom, cells after an 80-min (*arp2-2* and *myo3*Δ *myo5-1*) or a 160-min (*arp2-2 bni1-116 bnr1*Δ and *myo3*Δ *myo5-1 bni1-116 bnr1*Δ) incubation after release. Strains examined were Spc42p-GFP--expressing *arp2-2* (YKT1553), *arp2-2 bni1-116 bnr1*Δ (YKT1554), *myo3*Δ *myo5-1* (YKT1555), and *myo3*Δ *myo5-1 bni1-116 bnr1*Δ (YKT1556). (B) The *sla2-82* mutation inhibits small-bud formation in the *bni1-116 bnr1*Δ mutant. Spc42p-GFP--expressing *sla2-82* (YKT1557) and *sla2-82 bni1-116 bnr1*Δ (YKT1558) cells were arrested with α-factor, released into fresh medium at 37°C, fixed at the indicated time point, and analyzed as in A. Bottom, images of cells after an 80-min (*sla2-82*) or a 160-min (*sla2-82 bni1-116 bnr1*Δ) incubation after release. (C) The NPFXD-mediated endocytosis adaptors End3p and Sla1p are not required for small-bud formation in the *bni1-116 bnr1*Δ mutant. α-factor--arrested *end3*Δ *bni1-116 bnr1*Δ (YKT1600) and *sla1*Δ *bni1-116 bnr1*Δ (YKT1601) cells were released into fresh medium at 37°C, followed by a 160-min incubation. Numbers indicate the percentage of small-budded cells. It was reported that the *sla1*Δ mutant exhibited temperature-sensitive growth ([@B31]). The *sla1*Δ mutant in the BY4743 background did not grow at 37°C, but the *sla1*Δ mutant in the YEF473 background grew at 37°C (data not shown). We confirmed efficient small-bud formation in the *sla1*Δ *bni1-116 bnr1*Δ mutant in the BY4743 background as well as in the YEF473 background. Data shown are from cells in the BY4743 background. Bars, 5 μm.](zmk0071094100005){#F5}

In addition to the Arp2/3 complex and Myo3/5p, numerous proteins are involved in endocytosis as adaptors, scaffolds, and regulators of actin assembly ([@B60]). We next examined whether these proteins are also involved in small-bud formation in the *bni1-116 bnr1*Δ mutant. Sla2p, a homologue of mammalian HIP1 (Huntingtin-interacting protein 1), regulates rearrangement of actin patch assembly ([@B16]). End3p and Sla1p are members of the Pan1p complex, which links cargo proteins to clathrin-coated pits and sites of actin assembly in ubiquitin- and NPFXD-dependent endocytosis ([@B32]; [@B52]; [@B38]). We wanted to use an allele of *SLA2* that is defective in endocytosis but is not defective for growth, to eliminate possible secondary effects caused by a more severe allele; the *sla2*Δ mutant exhibited a severe temperature-sensitive growth defect and did not duplicate Spc42p-GFP even at 35°C after α-factor arrest-and-release (our unpublished results). The *sla2-82* mutant, which produces a mutant Sla2p protein lacking the C-terminal half (amino acids 491--968), shows a defect in endocytosis, but grows normally at 37°C ([@B87]); in the α-factor arrest-and-release assay at 37°C, time courses for Spc42p-GFP duplication and budding were similar to those of wild-type cells ([Figure 5](#F5){ref-type="fig"}B, data not shown). However, the *sla2-82 bni1-116 bnr1*Δ cells did not form a bud after an 80-min incubation, and even 160 min after release, only 10% of these cells exhibited a very tiny bud, which was much smaller than that in the *bni1-116 bnr1*Δ cells ([Figure 5](#F5){ref-type="fig"}B, data not shown). This budding defect was not due to a dominant effect of the truncated Sla2-82p, because it was suppressed by a *SLA2*-bearing plasmid (data not shown). The time courses for Spc42p-GFP duplication were similar for the *bni1-116 bnr1*Δ and *sla2-82 bni1-116 bnr1*Δ mutants (cf. [Figure 4](#F4){ref-type="fig"}B and [Figure 5](#F5){ref-type="fig"}B). In contrast to *SLA2*, loss of either *END3* or *SLA1* did not affect small-bud formation in the *bni1-116 bnr1*Δ cells. More than 90% of these cells were arrested with a small bud 160 min after release from G1 arrest ([Figure 5](#F5){ref-type="fig"}C). It should be noted that the budding phenotypes did not correlate with the growth phenotypes of the mutants; both *end3*Δ and *sla1*Δ mutants exhibited temperature-sensitive growth in contrast to the *sla2-82* mutant (data not shown). We confirmed that the budding defects were also observed in an asynchronous culture; more than 80% of the *arp2-2*, *myo3*Δ *myo5-1*, and *sla2-82* cells with *bni1-116 bnr1*Δ were arrested without a bud after a 3-h incubation at nonpermissive temperatures (our unpublished results). Taken together, these results suggest that the assembly of cortical actin patches can promote polarized bud growth by endocytosis in a manner independent of NPFXD-mediated endocytosis.

These results prompted us to examine endocytosis in the *tpm1-2 tpm2*Δ (ABY) mutant. Snc1p, an exocytic v-SNARE, cycles from the plasma membrane through early endosomes to the TGN along the endocytic recycling pathway ([@B47]). GFP-fused Snc1p is normally localized to polarized sites, such as a bud or a cytokinesis site, where exocytosis is actively occurring ([Figure 6](#F6){ref-type="fig"}A, wild type). When shifted to 37°C for 1 h, GFP-Snc1p accumulated intracellularly in the *bni1-116 bnr1*Δ (YEF) mutant as well as in the *tpm1-2 tpm2*Δ (YEF) mutant ([Figure 6](#F6){ref-type="fig"}A). Interestingly, GFP-Snc1p was seen as one or two large dots rather than uniform cytoplasmic staining. These structures may be endosomal compartments, because GFP-Snc1p was localized to similar large structures when coexpressed with the RFP-tagged Gcs1p ([@B64]), which is an ADP ribosylation factor (Arf)-GTPase--activating protein involved in the endocytic recycling pathway ([@B64]; [@B69]). In these compartments, endocytic recycling seems to be normal, because GFP-Snc1p was also localized to the plasma membrane ([@B64]); we confirmed that small-bud formation also occurred in GFP-Snc1p--expressing *bni1-116 bnr1*Δ and *tpm1-2 tpm2*Δ mutants (our unpublished results). This dot localization of Snc1p may be caused by the overexpression of GFP-tagged Snc1p, because neither clustered nor large membrane structures, but rather secretory vesicles were observed in EM-sectioning of *bni1-116 bnr1*Δ cells (data not shown). Nonetheless, there may be a mechanism that affects the morphology or localization of GFP-Snc1p--containing endosomal membranes when exocytotic vesicle transport is inhibited, because a large dot of GFP-Snc1p was not seen in wild-type cells ([Figure 6](#F6){ref-type="fig"}A).

![The *tpm1-2 tpm2*Δ mutant in the ABY944 background is defective in endocytosis of GFP-Snc1p. (A) Endocytosis of GFP-Snc1p is inhibited in the budding-deficient *tpm1-2 tpm2*Δ (ABY) mutant. Wild-type (YKT38), *bni1-116 bnr1*Δ (YKT503), *tpm1-2 tpm2*Δ (YEF) (YKT476), and *tpm1-2 tpm2*Δ (ABY) (YKT286) strains were transformed with pRS416-GFP-SNC1, and exponentially growing transformed cells were shifted to 37°C, followed by a 1-h incubation. (B) The budding defect in *bni1-116 bnr1*Δ mutants is associated with defects in GFP-Snc1p endocytosis. GFP-Snc1p localization was examined in *bni1-116 bnr1*Δ progeny shown in [Figure 2](#F2){ref-type="fig"}C as described in A. Bars, 5 μm.](zmk0071094100006){#F6}

Surprisingly, in the *tpm1-2 tpm2*Δ (ABY) mutant, GFP-Snc1p was uniformly localized to the plasma membrane and to some punctate structures beneath the plasma membrane that were reminiscent of early endosomal structures. These results suggest that the *tpm1-2 tpm2*Δ (ABY) mutant is somewhat deficient in endocytosis. Linkage of the unbudded phenotype to defects in endocytosis was confirmed in the *bni1-116 bnr1*Δ progeny described in [Figure 2](#F2){ref-type="fig"}C from the diploid of *bni1-116 bnr1*Δ (YEF) and *tpm1-2 tpm2*Δ (ABY); see [Figure 6](#F6){ref-type="fig"}B. We further observed the GFP-Snc1p localization in an additional four small-budded and four unbudded *bni1-116 bnr1*Δ progeny and obtained the same results (our unpublished results). These results are consistent with the notion that endocytosis is involved in small-bud formation in the absence of actin cables. Interestingly, defective endocytosis was not observed for the a-factor transporter Ste6p-GFP, which is normally endocytosed and transported to the vacuole ([@B39]); Ste6p-GFP was localized to the vacuole in the *tpm1-2 tpm2*Δ (ABY) mutant as well as in the wild type at 37°C (data not shown). One interesting possibility is that the mutation in the ABY genetic background might affect endocytosis specific to the endocytosis-recycling pathway, which is required for small-bud formation in the absence of actin cables (see below).

One interesting possibility for the budding defects in the *arp2-2 bni1-116 bnr1*Δ mutant cells would be that Cdc42p and other polarity regulators were not polarized in these cells. We examined the localization of polarity regulators in *end* (*arp2-2*, *myo3*Δ *myo5-1*, or *sla2-82*) *bni1-116 bnr1*Δ mutants released from G1 arrest at the nonpermissive temperature. After 60- and 80-min incubations, Cdc42p was localized at the presumptive bud site or at the bud tip in *arp2-2*, *myo3*Δ *myo5-1*, and *sla2-82* mutants, and the Cdc42p polarization to the presumptive bud site was also observed in *end* mutants carrying *bni1-116 bnr1*Δ mutations ([Figure 7](#F7){ref-type="fig"}). To confirm that these Cdc42p polarizations occurred through normal budding processes, we also monitored polarization of Bem1p-GFP, Spa2p-GFP, and Exo70p-GFP. Similar to Cdc42p, these polarity regulators were localized to the presumptive bud site. These results indicate that the initial cell polarization occurs normally in a mutant defective in both Arp2/3- and formin-mediated actin assemblies.

![Cdc42p and polarity regulators are polarized in the *bni1-116 bnr1*Δ mutant that is defective for Arp2/3-mediated actin polymerization. α-factor--arrested cells were released into fresh medium at 37°C, followed by fixation at the indicated time point. The graph shows the percentage of cells with polarization of Cdc42p or polarity regulators. Cdc42p and polarity regulators were visualized by immunofluorescence staining and GFP-tagging, respectively. Right, images of representative cells that polarized Cdc42p or GFP-fused polarity regulators after a 60-min incubation after release. Strains used were *arp2-2* (YKT478), *arp2-2 bni1-116 bnr1*Δ (YKT1546), *myo3*Δ *myo5-1* (YKT91), *myo3*Δ *myo5-1 bni1-116 bnr1*Δ (YKT1547), *sla2-82* (YKT850), and *sla2-82 bni1-116 bnr1*Δ (YKT1548), and GFP-tagged polarity regulator (Bem1p, Spa2p, and Exo70p)-expressing versions of these strains. Bar, 2 μm.](zmk0071094100007){#F7}

Small-Bud Formation in the bni1-116 bnr1Δ Mutant Requires the Endocytic Recycling Pathway
-----------------------------------------------------------------------------------------

Endocytosis is important for recycling secreted proteins and lipids to reuse them and to redirect growth throughout the cell cycle ([@B60]); endocytic recycling is one plausible mechanism that might underlie small-bud formation in the *bni1-116 bnr1*Δ mutant. We therefore examined the involvement of proteins that regulate the endocytic recycling pathway in small-bud formation in *bni1-116 bnr1*Δ cells ([Figure 8](#F8){ref-type="fig"}A). Tlg2p, an endosomal/*trans-*Golgi network (TGN) t-SNARE, is required for efficient fusion of early endosome-derived vesicles to the TGN ([@B47]). Vps54p is a component of the Golgi-associated retrograde protein (GARP) complex and is responsible for tethering vesicles derived from endosomes to the TGN ([@B73]; [@B13]). Both Tlg2p and Vps54p are involved in the endocytic recycling pathway. In contrast, Pep8p (Vps26p), a component of the retromer, functions in the late endosome-to-TGN retrieval pathway, but not in the early endosome-to-TGN retrieval pathway ([@B47]; [@B63]). *tlg2*Δ and *pep8*Δ mutants grew normally at 37°C, whereas the *vps54*Δ mutant showed a weak growth defect at 37°C in our strain background (data not shown). When released for 60 min at 37°C from G1 arrest, these mutants budded normally and progressed through the cell cycle in a normal manner except that the *vps54*Δ mutant exhibited a slight delay. In contrast, neither *tlg2*Δ *bni1-116 bnr1*Δ nor *vps54*Δ *bni1-116 bnr1*Δ cells formed a bud even 160 min after release, whereas *pep8*Δ *bni1-116 bnr1*Δ cells formed a small bud in a manner similar to that of *bni1-116 bnr1*Δ ([Figure 8](#F8){ref-type="fig"}A). The time course for Spc42p-GFP duplication in each triple mutant was similar to that in the *bni1-116 bnr1*Δ mutant except for a slight delay in the *vps54*Δ *bni1-116 bnr1*Δ mutant. These results indicate that the early endosome-to-TGN, but not the late endosome-to-TGN, retrograde transport pathway is required for small-bud formation in the absence of actin cable assembly.

![Endocytic recycling is required for small-bud formation in the *bni1-116 bnr1*Δ mutant. (A) A mutation in a gene that is involved in the endocytic recycling pathway inhibits small-bud formation in the *bni1-116 bnr1*Δ mutant. α-factor--arrested cells were released into fresh medium at 37°C, followed by fixation at the indicated time point. The graph shows the percentage of cells with Spc42p-GFP duplication (Spc42p) and the bud size categorized as in *Materials and Methods*. Bottom, images of cells after a 160-min incubation after release. Strains examined were Spc42p-GFP--expressing *tlg2*Δ (YKT1559), *tlg2*Δ *bni1-116 bnr1*Δ (YKT1560), *vps54*Δ (YKT1602), *vps54*Δ *bni1-116 bnr1*Δ (YKT1603), *pep8*Δ (YKT1605), and *pep8*Δ *bni1-116 bnr1*Δ (YKT1606). Bar, 5 μm. (B) Cdc42p and polarity regulators are polarized to the presumptive bud site in the *tlg2*Δ *bni1-116 bnr1*Δ mutant. α-factor--arrested cells were released into fresh medium at 37°C, followed by fixation at the indicated time point. The graph shows the percentage of cells showing polarization of polarity regulators. Bottom, images of representative polarized cells in the *tlg2*Δ *bni1-116 bnr1*Δ mutant after a 60-min incubation after release. Cdc42p was visualized by fluorescence immunostaining and other polarity regulators were visualized by GFP-tagging. *tlg2*Δ and *tlg2*Δ *bni1-116 bnr1*Δ mutants used were YKT955 and YKT1549 for Cdc42p, YKT1572 and YKT1573 for Bem1p-GFP, YKT1592 and YKT1593 for Spa2p-GFP, and YKT1582 and YKT1583 for Exo70p-GFP, respectively. Bar, 2 μm.](zmk0071094100008){#F8}

We next examined the localization of polarity-regulating factors in the *tlg2*Δ *bni1-116 bnr1*Δ mutant. G1-arrested cells were released at 37°C, and localization of Cdc42p, Bem1p-GFP, Spa2p-GFP, and Exo70p-GFP was examined. As shown in [Figure 8](#F8){ref-type="fig"}B, these polarity regulators were localized at the presumptive bud site with efficiency comparable to that in the *bni1-116 bnr1*Δ mutant (see [Figure 4](#F4){ref-type="fig"}). Thus, although actin cables and endocytic recycling have redundant functions for polarized bud growth, they do not seem to play important roles for the initial assembly of polarity regulators.

Myo2p Is Required for Small-Bud Formation in the bni1-116 bnr1Δ Mutant
----------------------------------------------------------------------

The endocytic recycling pathway for small-bud formation might use an unknown specialized pathway distinct from the conventional post-Golgi secretory pathway. We examined the effect of a late secretory pathway mutation, *sec4-2* (a mutation in a Rab family GTPase associated with post-Golgi secretory vesicles, [@B70]), on bud formation. The *sec4-2* mutant in the YEF473 genetic background was constructed by repeated backcrosses. G1-arrested cells were released at 33°C, because *sec4-2* cells did not duplicate the Spc42p-GFP dot at 35°C (data not shown). When released, most *sec4-2* cells (99%) did not form a bud even after 160 min ([Figure 9](#F9){ref-type="fig"}A), indicating that Sec4p is required for budding irrespective of actin cables. Taken together with the results that small-bud formation requires Tlg2p, the endosomal/TGN t-SNARE ([Figure 8](#F8){ref-type="fig"}A), these results suggest that, in the *bni1-116 bnr1*Δ mutant, endocytic vesicles for small-bud formation pass through the TGN, followed by formation of Sec4p-associated vesicles for delivery to the bud. We also examined the localization of Bem1p-GFP in the *sec4-2* mutant. Bem1p-GFP was polarized to the presumptive bud site in 45% of cells 60 min after release, suggesting that the late secretory pathway is not essential for the initial polarization of Bem1p. However, 160 min after release, Bem1p-GFP disappeared from the polarized sites in most cells (92%), suggesting that continuous vesicle flow is required for the maintenance of polarized Bem1p. Sustained polarization of Bem1p-GFP 160 min after release in *bni1-116 bnr1*Δ cells ([Figure 4](#F4){ref-type="fig"}C) seems to be supported by polarized transport of vesicles containing a membrane-bound polarity regulator (e.g., Cdc42p).

![The late secretory pathway and the type V myosin Myo2p are required for bud formation. (A) Requirement of Sec4p for budding but not for Bem1p-GFP polarization. α-factor--arrested cells were released into fresh medium at 33°C, followed by fixation at the indicated time point. Left, an image of cells after a 160-min incubation after release, and the number indicates the percentage of small-budded cells. The graph shows the percentage of cells with Spc42p-GFP duplication (Spc42p) and polarized Bem1p-GFP (Bem1p). Right, representative cells with polarized Bem1p-GFP after a 60-min incubation. Strains examined were *sec4-2* mutants expressing Spc42p-GFP (YKT1608) or Bem1p-GFP (YKT1611). Bars, 5 and 2 μm for left and right panels, respectively. (B) Requirement of Myo2p for budding but not for Bem1p-GFP polarization. α-factor--arrested cells were released into fresh medium at 32°C (*myo2-66*), 36.5°C (*myo2-12*), or 37°C (*myo2-20*), followed by fixation at the indicated time point. The results are presented as described in A. Strains examined were *myo2-66*, *myo2-12*, and *myo2-20* mutants expressing Spc42p-GFP (YKT1610, YKT1679, and YKT1677, respectively) or Bem1p-GFP (YKT1612, YKT1680, and YKT1681, respectively). (C) Polarized localization of Myo2p-GFP in the *bni1-116 bnr1*Δ mutant requires the endocytosis-recycling pathway and a regulator of the Arp2/3p-dependent actin polymerization. α-factor--arrested strains were released into fresh medium at 37°C, followed by fixation after a 60-min incubation after release. Myo2p-GFP--expressing strains were *bni1-116 bnr1*Δ (YKT791), *myo3*Δ *myo5-1 bni1-116 bnr1*Δ (YKT1614), *sla2-82 bni1-116 bnr1*Δ (YKT1615), and *tlg2*Δ *bni1-116 bnr1*Δ (YKT1617). Numbers indicate the percentage of cells having polarized Myo2p-GFP. Bar, 2 μm.](zmk0071094100009){#F9}

Even though bud formation in the *bni1-116 bnr1*Δ mutant was inefficient, it may still be dependent on directional transport of vesicles. We examined the role of Myo2p for bud formation. The *myo2-66* allele encodes a protein with a single amino acid substitution (E511K) in an actin-binding motor domain ([@B48]), whereas *myo2-12* and *myo2-20* alleles encode proteins with amino acid substitutions in a cargo-binding tail domain ([@B71]). These *myo2* mutants in the YEF473 genetic background were constructed by repeated backcrosses. G1-arrested *myo2-66* cells were released at 32°C, because the *myo2-66* cells did not duplicate the Spc42p-GFP dot at 33°C (data not shown), whereas the *myo2-12* and *myo2-20* cells were released at 36.5 and 37°C, respectively. When released, most *myo2-66* (94%), *myo2-12* (90%), and *myo2-20* (88%) cells did not form a bud even after 160 min ([Figure 9](#F9){ref-type="fig"}B), indicating that Myo2p is also required for budding irrespective of actin cables. These results suggest that, in the *bni1-116 bnr1*Δ mutant, Myo2p transports vesicles along actin filaments that are formin-independent or that it has functions that are not dependent on actin filaments. Bem1p-GFP was also polarized to the presumptive bud site in *myo2* mutant cells ([Figure 9](#F9){ref-type="fig"}B), suggesting that Myo2p-mediated transport is not essential for polarized localization of Bem1p. However, polarized localization of Bem1p-GFP was specifically lost in the *myo2-66* mutant 160 min after release. This defect could be because the *myo2-66* mutant was already sick at a permissive temperature, but it is also possible that Myo2p is required for the sustained localization of Bem1p-GFP at the presumptive bud site and that *myo2-12* and *myo2-20* mutants are not defective in interaction with a vesicle containing a polarity factor (e.g., Cdc42p).

As described in the first paragraph of *Results*, Myo2p-GFP rapidly disappeared (∼5 min) from polarized sites in the *bni1-116 bnr1*Δ mutant after shift to 35°C. However, a fraction of Myo2p, which seems to function in small-bud formation in the *bni1-116 bnr1*Δ mutant, may be visualized at the bud tip by careful microscopic examination. We examined the localization of C-terminally GFP-fused Myo2p in *bni1-116 bnr1*Δ cells released from G1 arrest. Sixty minutes after release, Myo2p-GFP signals could be seen at the presumptive bud site or the bud tip in 18% of *bni1-116 bnr1*Δ cells. However, Myo2p-GFP did not polarize in *bni1-116 bnr1*Δ mutants carrying mutations in the endocytosis-recycling pathway, including *myo3*Δ *myo5-1*, *sla2-82*, and *tlg2*Δ ([Figure 9](#F9){ref-type="fig"}C), and this was the case even 160 min after release (our unpublished results). These results may suggest that the endocytosis-recycling pathway is required for localization or maintenance of a factor that is involved in polarized localization of Myo2p. One intriguing possibility is that this factor is involved in the assembly of actin structures for Myo2p-driven vesicle transport.

DISCUSSION
==========

Initial Polarized Bud Growth in the Absence of Actin Cables
-----------------------------------------------------------

In this study, we have shown herein that the budding yeast can form a small bud even in the absence of actin cables, which are assembled by formins and are stabilized by tropomyosins. Our results parallels the observation made in the fission yeast *Schizosaccharomyces pombe*; cells lacking the formin for3p still grow quite well without actin cables ([@B20]). Therefore, it seems that both budding and fission yeast possess a conserved mechanism to promote polarized growth in an actin cable-independent manner and that actin cables function as a facilitator rather than an essential factor for polarized growth. This actin cable-independent bud formation may represent a fundamental mechanism for initial polarization in eukaryotic cells.

Our finding of small-bud formation in the *bni1-116 bnr1*Δ mutant was unexpected, because the previously reported *bni1-11 bnr1*Δ and *tpm1-2 tpm2*Δ mutants exhibited defects in budding ([@B62]; [@B18]). We have shown that these discrepancies were possibly due to a single recessive mutation in the ABY genetic background used in the above studies. This mutation, which rendered our *bni1-116 bnr1*Δ mutant defective for small-bud formation, partially inhibited endocytosis of GFP-Snc1p, consistent with the notion that the endocytosis-recycling pathway is required for small-bud formation in the absence of actin cables.

The Endocytosis-recycling Pathway as an Engine to Promote Polarized Membrane Growth
-----------------------------------------------------------------------------------

We have shown that the Arp2/3p complex and its activators, whose major role seems to be to promote endocytosis, are required for small-bud formation in the absence of actin cables. Small-bud formation also required factors (Tlg2p and Vps54p) that are involved in early endosome-to-TGN vesicle transport. These results strongly suggest that the budding yeast possesses a second mechanism for polarized growth: budding by endocytosis and recycling of vesicles. Endocytic recycling plays a pivotal role in cell morphogenesis in various cell types ([@B45]; [@B23]; [@B40]; [@B46]; [@B74]; [@B29]). Our results suggest that a mechanism for cell polarization by endocytic recycling is conserved throughout evolution. Thus, yeast cells would provide a useful model system for dissection of the molecular mechanisms underlying the endocytosis-recycling pathway for cell polarization.

Specificity of the endocytic recycling pathway for small-bud formation was suggested by our observations that small-bud formation required neither Sla1p nor End3p, components of the Sla1p/Pan1p/End3p endocytic complex ([@B75]; [@B76]), which are involved in ubiquitin- and NPFXD-dependent endocytosis ([@B32]; [@B52]). A mutation in the ABY genetic background inhibited endocytosis of GFP-Snc1p, but not that of Ste6p-GFP, which is known to be endocytosed in a ubiquitin-dependent manner ([@B41]; [@B39]). Identification of this gene would be an interesting next step to analyze the molecular mechanisms of endocytic recycling-promoted polarized growth.

Endocytic recycling and actin cable-dependent vesicle transport has been implicated in polarization of various membrane proteins such as the v-SNARE Snc1p ([@B79]), the chitin synthase III Chs3p ([@B12]; [@B30]; [@B80]), the cell wall stress sensor Wsc1p ([@B57]), the a-factor receptor Ste3p ([@B11]), and the phospholipid translocase Dnf1p ([@B68]). We have first demonstrated that the endocytic recycling pathway is also involved in membrane remodeling (polarized growth) in budding yeast. Two plausible functions could be envisioned. One is to maintain a membrane protein required for polarized growth at the polarized site. These membrane proteins may include those involved in exocytosis or actin reorganization. Interestingly, a mutation in the ABY genetic background partially inhibited endocytosis of the v-SNARE Snc1p, but not that of Ste6p. Efficient recycling of Snc1p may be required for small-bud formation when actin cable--dependent vesicle transport is compromised. The other function may be to supply new membranes to the bud. In this case, endocytosis from the mother plasma membrane, but not from the bud membrane, would be required for efficient polarized growth. However, we have shown that the post-Golgi Sec4p-dependent exocytotic pathway is required for small-bud formation. These results suggest that newly synthesized membranes can also contribute to small-bud formation by merging at the TGN with endocytic membranes. Nonetheless, we should not rule out the possibility that a specific TGN compartment is generated from endocytic membranes and that this TGN compartment is used for small-bud formation in the absence of actin cable-dependent vesicle transport.

Roles of endocytic recycling for small-bud formation and polarized localization of membrane proteins suggest that early endosomes could be localized in a polarized manner. Yeast early endosomes are observed as scattered dotty structures, but we cannot discriminate between early endosomes for vacuolar sorting and those for endocytic recycling ([@B47]). It was previously reported that the early endosome-to-TGN transport was specifically blocked in *rcy1* and *cdc50* mutants ([@B83]; [@B21]). These mutants accumulated enlarged early endosomal membranes, probably due to defects in vesicle budding from early endosomes. Interestingly, these enlarged endosomal membranes were localized in the bud or near the bud neck ([@B83]; [@B21]), suggesting a mechanism that localizes endosomal membranes in a polarized manner. It is an interesting question whether this polarized localization of endosomal membranes is independent of actin cables.

Roles of the Actin Cytoskeleton in the Polarized Membrane Growth in the Absence of Actin Cables
-----------------------------------------------------------------------------------------------

One important question is how exocytotic vesicles are transported in a polarized manner in formin and tropomyosin mutants. The *myo2* mutants exhibited a budding defect and Myo2p-GFP was localized to the bud tip in the *bni1-116 bnr1*Δ mutant, suggesting that Myo2p transports vesicles toward the bud tip along some type of actin structure in the absence of actin cables. On the other hand, it was shown that a small fraction of Myo2p could be localized to the bud site possibly by passive diffusion in the presence of an actin inhibitor latrunculin-A ([@B3]), and we confirmed their results for Myo2p-GFP in our strain background (data not shown). Therefore, further work is needed to know whether Myo2p is transported along actin structures in the absence of actin cables. However, efficient polarized growth in the *for3* mutant does not seem to be accounted for by passive diffusion. Interestingly, a Sla2p homologue is required for polarized cell growth in *Schizosaccharomyces pombe* ([@B10]; [@B22]). In addition, involvement of a WASP homologue and type I myosins in polarized growth has also been shown in the pathogenic fungus *Candida albicans*; mutants in these genes exhibit defects in hyphal growth ([@B55]; [@B81]). It is an intriguing possibility that these potential Arp2/3 regulators including those in budding yeast might regulate actin reorganization for polarized vesicle transport.

Recently, it was reported that budding yeast cells formed a small bud in the absence of actin assembly ([@B67]). In this report, quiescent cells from a 7-d-old culture were released into fresh medium containing 200 μM actin inhibitor latrunculin-A. In our α-factor arrest-and-release assay, 100 μM latrunculin-A completely inhibited budding as also reported for cells in stationary phase (data not shown; [@B3]; [@B5]). Seven-day-old G0 cells might be physiologically very different from cells in the growth cycle, as suggested by the authors, but it would be difficult to imagine that a cell achieves efficient budding with only a cortical polarity scaffold and passive diffusion of secretory vesicles. It seems that there should be an alternative route to actin guidance in the budding from 7-d-old cells.

Roles of the Actin Cytoskeleton for Initial Cell Polarization
-------------------------------------------------------------

Assembly of polarity regulators in the absence of the actin cytoskeleton was first reported by [@B3]. They showed that Cdc42p and Bem1p were localized to the incipient bud site with wild-type kinetics when G0-arrested cells were released in the presence of latrunculin-A. Our current results are consistent with their results. Cdc42p and polarity regulators were polarized normally in the absence of components for two major actin structures in yeast, actin cables and cortical actin patches (e.g., in the *arp2-2 bni1-116 bnr1*Δ mutant). Therefore, it seems that the scaffolding activities of upstream regulators including Cdc24p and Bem1p are enough for the initial assembly of Cdc42p. A mutant deficient only in actin cables (e.g., the *tpm1-2 tpm2*Δ mutant) also polarized Cdc42p and even formed a small bud. In contrast, in the *tpm1-2 tpm2*Δ mutant in the ABY genetic background, Cdc42p was initially polarized but rapidly dispersed ([@B34]); we confirmed that the *tpm1-2 tpm2*Δ (ABY) mutant failed to polarize Cdc42p after α-factor arrest-and-release ([Figure 4](#F4){ref-type="fig"}B). [@B34] proposed that this dispersal was caused by endocytosis of Cdc42p and demonstrated that the Cdc42p dispersal was suppressed by a blockade of endocytosis. How endocytosis of Cdc42p is involved in Cdc42p polarization is an interesting question. Endocytosis can antagonize Cdc42p polarization by promoting dispersal of Cdc42p from a polarized site, but endocytosis and subsequent recycling of Cdc42p to the polarized site can promote Cdc42p polarization as hypothesized by [@B51]. Therefore, the endocytosis-recycling pathway could be a third pathway for Cdc42p polarization in addition to the scaffold-mediated assembly pathway and the actin cable--dependent vesicle transport pathway ([@B84]). We showed that the *tpm1-2 tpm2*Δ (ABY) mutant was partially defective in endocytosis of GFP-Snc1p. If the endocytosis-recycling pathway plays some role in the maintenance of Cdc42p at the polarized site in the actin cableless mutant, partial defects in endocytosis would enhance dispersal of Cdc42p by slowing down the redelivery of Cdc42p to the plasma membrane. In contrast, strong inhibition of endocytosis would leave Cdc42p localized at the polarized site as demonstrated by [@B34] and this study.

In conclusion, we think that the role of the actin cytoskeleton for the initial polarization of Cdc42p remains obscure. However, in a mutant in which the scaffold-mediated assembly pathway is compromised (e.g., the *bem1* mutant), treatment with latrunculin-A inhibits polarization of Cdc42p ([@B84]; our unpublished results), indicating that actin-dependent processes play a compensating role for the initial polarization of Cdc42p. Whether this compensation is brought about by actin cable (formins)- and/or cortical actin patch (Arp2/3)-dependent processes remains a fascinating question.
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